No association between N-acetyltransferase 2 (NAT2) and risk of diffuse type of gastric cancer

被引：2
|
作者：
Hosseini, Hedayatollah [1 ]
Dovranehgard, Fatemeh [2 ]
Arveysi, Sorya [2 ]
Galehdari, Hamid [3 ]
Masjedizadeh, Abdolrahim [1 ]
Shanaki, Mehrnoosh [1 ]
机构：
[1] Jondi Shapur Univ Med Sceince, Dept Biochem, Ahvaz, Iran
[2] Razi Univ, Dept Biol, Kermanshah, Iran
[3] Shahid Chamran Univ, Dept Genet, Ahvaz, Iran
来源：
TOXICOLOGY LETTERS | 2009年 / 189卷
关键词：
D O I：
10.1016/j.toxlet.2009.06.729
中图分类号：
R99 [毒物学（毒理学）];
学科分类号：
100405 ;
摘要：
引用
收藏
页码：S138 / S138
页数：1
相关论文
共 50 条
  • [21] Arylamine N-acetyltransferase (NAT2) genotypes in a Turkish population
    Aynacioglu, AS
    Cascorbi, I
    Mrozikiewicz, PM
    Roots, I
    PHARMACOGENETICS, 1997, 7 (04): : 327 - 331
  • [22] Polymorphisms of arylamine N-acetyltransferase (NAT1 and NAT2) and larynx cancer susceptibility
    Varzim, G
    Monteiro, E
    Silva, R
    Pinheiro, C
    Lopes, C
    ORL-JOURNAL FOR OTO-RHINO-LARYNGOLOGY AND ITS RELATED SPECIALTIES, 2002, 64 (03): : 206 - 212
  • [23] Clinical relevance of N-acetyltransferase (NAT2) genetic polymorphism
    Furet, Y
    Bechtel, Y
    Le Guellec, C
    Bechtel, PR
    Autret-Leca, E
    Paintaud, G
    THERAPIE, 2002, 57 (05): : 427 - 431
  • [24] Active cigarette smoking and the risk of breast cancer at the level of N-acetyltransferase 2 (NAT2) gene polymorphisms
    Kasajova, Petra
    Holubekova, Veronika
    Mendelova, Andrea
    Lasabova, Zora
    Zubor, Pavol
    Kudela, Erik
    Biskupska-Bodova, Kristina
    Danko, Jan
    TUMOR BIOLOGY, 2016, 37 (06) : 7929 - 7937
  • [25] THE ROLE OF GENETIC POLYMORPHISMS OF N-ACETYLTRANSFERASE 2 (NAT2) ENZYME IN THE RISK OF BLADDER CANCER IN THE LEBANESE POPULATION
    Khoueiry-Zgheib, N.
    Nasr, R.
    Temraz, S.
    Shamseddin, A.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2014, 115 : 172 - 172
  • [26] Ultra-slow N-acetyltransferase 2 (NAT2) and relapses in bladder cancer patients
    Selinski, Silvia
    Geis, Berit C.
    Gerullis, Holger
    Otto, Thomas
    Roth, Emanuel
    Volkert, Frank
    Ovsiannikov, Daniel
    Salem, Johannes
    Moormann, Oliver
    Niedner, Hartmut
    Blaszkewicz, Meinolf
    Hengstler, Jan G.
    Golka, Klaus
    TOXICOLOGY LETTERS, 2017, 280 : S240 - S241
  • [27] Ultra-slow N-acetyltransferase 2 (NAT2) and prognosis in bladder cancer patients
    Selinski, S.
    Geis, B.
    Gerullis, H.
    Otto, T.
    Roth, E.
    Volkert, F.
    Ovsiannikov, D.
    Salem, J.
    Moormann, O.
    Niedner, H.
    Blaszkewicz, M.
    Hengstler, J. G.
    Golka, K.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2016, 389 (01) : S57 - S57
  • [28] Slow N-acetyltransferase 2 (NAT2) acetylation state as a susceptibility factor for bladder cancer
    Reckwitz, T
    Weistenhöfer, W
    Farker, K
    Prior, V
    Seidel, T
    Schubert, J
    Zumbe, J
    Dietrich, H
    Golka, K
    Schulze, H
    JOURNAL OF UROLOGY, 2003, 169 (04): : 140 - 140
  • [29] Investigation of interaction between N-acetyltransferase 2 (NAT2) phenotype and heterocyclic amines as potential risk factors for colorectal cancer.
    Barrett, JH
    Bishop, DT
    Waxman, R
    Forman, D
    Lightfoot, T
    Garner, C
    Smith, G
    Wolf, R
    AMERICAN JOURNAL OF HUMAN GENETICS, 2001, 69 (04) : 263 - 263
  • [30] N-acetyltransferase 2 (Nat2) polymorphism in the sand rat Psammomys obesus
    Khelil, Malika
    Djerdjouri, Bahia
    Tayebi, Bouchentouf
    TOXICOLOGY MECHANISMS AND METHODS, 2010, 20 (08): : 440 - 444
12345